title: Letter to the editor regarding: "Pharmacokinetics of teneligliptin in subjects with renal impairment." Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.
authors.affiliation: Boehringer Ingelheim, Ingelheim, Germany.
authors.forename: Ulrike
authors.initials: U
authors.lastname: Graefe-Mody
authors.affiliation: Boehringer Ingelheim, Biberach, Germany (current address: Bayer Healthcare, Berlin, Germany).
authors.forename: Christian
authors.initials: C
authors.lastname: Friedrich
authors.affiliation: Boehringer Ingelheim, Ingelheim, Germany.
authors.forename: Maximilian
authors.initials: M
authors.lastname: von Eynatten
authors.affiliation: Boehringer Ingelheim, Ingelheim, Germany.
authors.forename: Sandra
authors.initials: S
authors.lastname: Thiemann
authors.affiliation: Profil, Neuss, Germany.
authors.forename: Tim
authors.initials: T
authors.lastname: Heise
authors.affiliation: Boehringer Ingelheim, Ingelheim, Germany.
authors.forename: Hans-Juergen
authors.initials: HJ
authors.lastname: Woerle